Australia's largest stock trading and investment forum Australia's #1 stock forum

CGB

Click for more information

0.00%

2.1¢ cann global limited

Next year now

First 91 Last

Share
Profile

Follow
Tahora

1,034 Posts.

176

03/10/22

11:51

Post #: 63997672
Share

Originally posted by Aussie Eagle: ↑

Lol..how right you are @Tahora !
No surprises there with an extra 2-wks ('max') suspension to Fri 14th

I'd reckon the 'target' is doing heaps of extra background checking as they should, moreso because of it being CGB and the personnel on the BoD here - including the recently departed.
Neither Pnina Feldman nor John Easterling have been replaced so Sholom will be selling that point to the target for starters.

One of the other problems may be the fact that they tried to woo HHI into a takeover with advancing cash, then reclaiming it when the t/o failed.

Also, we have the ongoing Court Case where CGB refuse to pay their Contractor, Medcan.

Not a good look and imo any t/o target would be extremely wary, rightly so, of getting into bed with CGB.

The deal would have to be continuously sweetened and one of the avenues would undoubetedly be to the detriment (once again) of current shareholders, imo.

Expand

Next year now

CGB Price at posting: 2.1¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

TNC

True North increases silver metal at QLD's Vero deposit by 20%

Revolutionary inverter technology leads the clean energy charge

Bitcoin: Current State of Play & Where to Next | Swyftx

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Emerald & Azure score Digger & Dealer awards

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

There are more pages in this discussion • 53 more messages in this thread...

First 91 Last

Add CGB (ASX) to my watchlist